Association of statins with thyroid adverse events: A pharmacovigilance study combining real-world and US FAERS/Canadian CVARD databases

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomaterial-based drug delivery: evaluating the safety profiles of liposomal Vyxeos

  2025cited by this paper
• Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)

  2022cited by this paper
• Adverse Drug Reactions in Canada (2009-2018): Insights from the Canada Vigilance Database.

  2020cited by this paper
• Statin-induced GGPP depletion blocks macropinocytosis and starves cells with oncogenic defects

  2020cited by this paper
• OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications

  2016cited by this paper
• Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

  2015cited by this paper
• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Disproportionality methods for pharmacovigilance in longitudinal observational databases

  2013cited by this paper
• Unbalanced estrogen metabolism in thyroid cancer

  2013cited by this paper
• Role of Estrogen in Thyroid Function and Growth Regulation

  2011cited by this paper
• Effect of two intensive statin regimens on progression of coronary disease.

  2011cited by this paper
• Sterol metabolism and SREBP activation.

  2010cited by this paper
• Quantitative signal detection using spontaneous ADR reporting

  2009cited by this paper
• Screening statins for possible carcinogenic risk: up to 9 years of follow‐up of 361 859 recipients

  2008cited by this paper
• HMG-CoA reductase inhibitors (statins) might cause high elevations of creatine phosphokinase (CK) in patients with unnoticed hypothyroidism.

  2006cited by this paper
• Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells.

  2003cited by this paper
• A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions

  2002cited by this paper
• Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

  2001cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Estrogen Promotes Growth of Human Thyroid Tumor Cells by Different Molecular Mechanisms*

  year unknowncited by this paper

• No citing papers are available for this paper.